Fructoholism in adults: The importance of personalised care in metabolic dysfunction-associated fatty liver disease

Herein, we report the case of a 64-year-old woman followed-up by an endocrinology clinic since 2001, for a metabolic syndrome characterised by abdominal adiposity, type 2 diabetes, dyslipidaemia and hypertension. Due to the development of liver test disturbances in 2020, the patient was referred to hepatology. Transient elastography revealed steatosis and a stage F1 fibrosis (Table 1). With those positive diagnostic criteria, the diagnosis of metabolic dysfunction-associated fatty liver disease (MAFLD) was made.